America’s drug regulator is in turmoil

[ad_1] TO APPRECIATE the dilemmas the Food and Drug Administration (FDA) faces when it reviews new drugs targeting rare diseases, consider the recent rollercoaster ride of Sarepta Therapeutics, a biotech firm. In 2023 the FDA…

Sebi bans Jane Street! What measures regulator may…

[ad_1] The Indian stock market regulator's action against Jane Street after the alleged index manipulation came to light has reignited concerns over just how exposed and powerless retail traders remain in the high-stakes world of…